MYC and hepatocellular carcinoma: As expected, our results confirmed that lncCSMD1 specifically protects MYC from degradation via inhibiting the ubiquitin-proteasome pathway, which stabilizes MYC protein, and simultaneously enhances MYC signaling pathway in HCC cells.